Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   The mechanism of Raf activation through dimerization
  2. Zhang,Mingzhen; Maloney,Ryan; Jang,Hyunbum; Nussinov,Ruth
  3. Chemical Science. 2021, Dec 08; 12(47): 15609-15619.
  1. 2.   Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases
  2. Kondo, Yasushi; Ognjenovic,Jana; Banerjee, Saikat; Karandur, Deepti; Merk,Alan; Kulhanek, Kayla; Wong, Kathryn; Roose, Jeroen P.; Subramaniam, Sriram; Kuriyan, John
  3. SCIENCE. 2019, OCT 4; 366(6461): 109-+.
  1. 3.   Allosteric activation of RAF in the MAPK signaling pathway
  2. Tsai,Chung-Jung; Nussinov,Ruth
  3. CURRENT OPINION IN STRUCTURAL BIOLOGY. 2018, Dec; 53: 100-106.
  1. 4.   TRPM7 is essential for Mg2+ homeostasis in mammals
  2. Ryazanova, L. V.; Rondon, L. J.; Zierler, S.; Hu, Z. X.; Galli, J.; Yamaguchi, T. P.; Mazur, A.; Fleig, A.; Ryazanov, A. G.
  3. Nature Communications. 2010, Nov; 1: 9.
  1. 5.   The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis
  2. Qu, W.; Liu, J.; Fuquay, R.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Cancer Letters. 2007, Oct; 256(2): 238-245.
  1. 6.   Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2
  2. Price, P. M.; Yu, F.; Kaldis, P.; Aleem, E.; Nowak, G.; Safirstein, R. L.; Megyesi, J.
  3. Journal of the American Society of Nephrology. 2006, Sep; 17(9): 2434-2442.
  1. 7.   Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Hu, C. A.; Phang, J. M.
  3. Oncogene. 2006, Sep; 25(41): 5640-5647.
  1. 8.   The RIO kinases: An atypical protein kinase family required for ribosome biogenesis and cell cycle progression
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2005, DEC 30; 1754(1-2, Sp. Iss.): 14-24.
  1. 9.   A family portrait of the RIO kinases
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Journal of Biological Chemistry. 2005, NOV 11; 280(45): 37297-37300.
  1. 10.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 11.   Autophosphorylation of Archaeoglobus fulgidus Rio2 and crystal structures of its nucleotide-metal ion complexes
  2. Laronde-Leblanc, N.; Guszczynski, T.; Copeland, T.; Wlodawer, A.
  3. Febs Journal. 2005, JUN; 272(11): 2800-2810.
  1. 12.   Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia
  2. Bi, X. L.; Yang, J. Y.; Dong, Y. X.; Wang, J. M.; Cui, Y. H.; Ikeshima, T.; Zhao, Y. Q.; Wu, C. F.
  3. International Immunopharmacology. 2005, JAN; 5(1): 185-193.
  1. 13.   Characterization of an S-locus receptor protein kinase-like gene from peach
  2. Bassett, C. L.; Nickerson, M. L.; Farrell, R. E.; Artlip, T. S.; El Ghaouth, A.; Wilson, C. L.; Wisniewski, M. E.
  3. Tree Physiology. 2005 25(4): 403-411.
  1. 14.   Crystal structure of A-fulgidus Rio2 defines a new family of serine protein kinases
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Structure. 2004, SEP; 12(9): 1585-1594.
  1. 15.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 16.   Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state
  2. Chatti, K.; Farrar, W. L.; Duhe, R. J.
  3. Biochemistry. 2004 43(14): 4272-4283.
  1. 17.   Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
  2. Findlay, V. J.; Townsend, D. M.; Saavedra, J. E.; Buzard, G. S.; Citro, M. L.; Keefer, L. K.; Ji, X. H.; Tew, K. D.
  3. Molecular Pharmacology. 2004 65(5): 1070-1079.
  1. 18.   Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells
  2. Conze, D.; Weiss, L.; Regen, P. S.; Bhushan, A.; Weaver, D.; Johnson, P.; Rincon, M.
  3. Cancer Research. 2001 61(24): 8851-8858.
  1. 19.   Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway
  2. Chie, L.; Amar, S.; Kung, H. F.; Lin, M. C. M.; Chen, H.; Chung, D. L.; Adler, V.; Ronai, Z.; Friedman, F. K.; Robinson, R. C.; Kovac, C.; Brandt-Rauf, P. W.; Yamaizumi, Z.; Michl, J.; Pincus, M. R.
  3. Cancer Chemotherapy and Pharmacology. 2000 45(6): 441-449.
  1. 20.   Ras oncogene-induced sensitization to 1-beta-D-arabinofuranosylcytosine
  2. Koo, H. M.; McWilliams, M. J.; Alvord, W. G.; Woude, G. F. V.
  3. Cancer Research. 1999 59(24): 6057-6062.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel